-PLX-61639, a selective, oral SMARCA2 degrader, demonstrated sustained PD response and single-agent efficacy in SMARCA4 mutant tumors; program is advancing through IND-enabling studies- -PLX-4545,...

Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary genome-wide methylome enrichment technology, presented...

Wacker Chemical Corporation presents binder technology for feminine hygiene, wipes, tabletop, and filtration at the IDEA 2025 tradeshow in Miami Beach, Florida, from April 29 to May 1, 2025. Our...

SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of treatments for disorders of the central...

Indusface, a global leader in application security, announced the launch of its fully integrated, AI-powered platform for continuous Exposure Management, Vulnerability Management and Autonomous...